Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32512 total
TRAX heads into its August 13 earnings report on the back of a 32% surge over the past month — a move driven by clinical newsflow but now demanding validation from the numbers. The analyst community has responded to…
Andersen Group Inc. reports after the close on August 12 with a notable tension at its core: short sellers have been adding aggressively even as the stock has rallied sharply past where analysts think it should…
MPLT enters its August 14 print carrying the scars of a dramatic analyst reset — and the question heading into Thursday is whether the ZEPHYR Phase 2b data can reopen the bull case that was closed so abruptly two weeks…
Fermi Inc. reports on August 13 with analysts having dramatically reduced their expectations over recent months — a pattern that frames the core debate around whether the company's delayed revenue story is already…
The most striking signal heading into NIQ Global Intelligence's August 13 earnings is not in the options market or the short book — it's the CEO's own wallet. James Peck bought $1 million of NIQ stock at $8.43 in May,…
FLOC heads into its August 11 earnings print with short sellers cutting exposure even as the stock rallies — a divergence that frames the debate around how durable the company's oilfield services recovery really…
Septerna heads into its August 11 Q2 earnings report with options markets flashing the most defensive posture seen in months. The sharpest pre-earnings signal is in the options market. The put/call ratio jumped to 0.53…
Amentum Holdings reports today against a backdrop of rising short interest, a recovering share price, and a Street that has been quietly trimming its expectations for months. Short sellers have been adding steadily.…
CeriBell reports after the close today with a notable insider selling pattern as the clearest signal heading into the print. CEO Xingjuan (Jane) Chao has sold shares on three separate occasions since early June —…
ALMS heads into its August 13 earnings print with short sellers rapidly unwinding positions and options traders leaning decisively toward calls over puts. The positioning shift is striking. Short interest has collapsed…
WBTN heads into its August 11 earnings print with options traders positioned more defensively than at any point in recent months, even as the lending market has loosened considerably from its tightest levels. The…
OKLO heads into its August 12 results with the stock down 8% in a single session and short sellers not backing away — a setup that sharpens the stakes considerably after last week's brief rally. The post-earnings…
PACS Group heads into its August 12 earnings report with the analyst community notably more constructive than it was just one week ago — and the stock has moved sharply to close that gap. The most telling development…
Biohaven Ltd. heads into tonight's earnings report with short sellers visibly retreating but the broader debate over BHV-7000's clinical future unresolved. The most striking feature of the setup is how far short…
MoonLake Immunotherapeutics heads into Wednesday's earnings release carrying a visible insider selling overhang and a stock that has lost 15% in the past month alone. The most pointed signal ahead of the print is…
Alpha Tau Medical reports Tuesday after the bell, entering the print off a sharp rally that has now stretched to 14% over the past week and roughly 7% on the month, with the stock at $13.60. The most telling…
Semiconductor equipment makers swept higher in analyst target prices today. Applied Materials, KLA Corporation, and Lam Research all received upward target revisions in a coordinated sector move. AMAT's consensus…
KBDC heads into its August 11 earnings print as the clear laggard in a BDC sector that has been surging around it. The peer gap is the sharpest tension in the setup. Across the most closely correlated names, weekly…
Archer Aviation reports Q2 results on August 13 with a short base that survived a 29% weekly rally without breaking — a tension that makes the print more charged than usual. The short position is large and stubborn. At…
Vera Therapeutics reports Q2 results on August 13 with the stock under real pressure — down 25% over the past month and trading at $31.58, against a bull consensus that sees fair value more than twice as high. The most…
